Head to head
Skyworks Solutions vs NVIDIA
Side-by-side on the measures that matter, with a plain-English read. Full detail: SWKS · NVDA
SWKS
Skyworks Solutions
73.91-6.04%
1-year price shape — +25% over the period
Quant Rating C · 65/100
vs
NVDA
NVIDIA
125.53-14.01%
1-year price shape — -30% over the period
Quant Rating E · 13/100
1-year performance, rebased to 100
NVIDIA edges it on the scoreable measures. NVIDIA trades cheapest on trailing earnings; NVIDIA earns the most per share.
| SWKS | NVDA | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 73.91 | 125.53 |
| Change today | -6.04% | -14.01% |
| 1-year return | +24.7% | -30.4% |
| Market cap | $17.36B | $3.03T |
| 52-week range | 51.48 – 93.24 | 124.50 – 243.37 |
| Valuation | ||
| P/E (TTM) | 64.83 | 13.48 |
| P/E percentile, own 5-yr range | 100th | 0th |
| P/B | 3.04 | 11.34 |
| Dividend yield | 2.88% | 0.41% |
| Profitability & growth | ||
| EPS (TTM) | 1.14 | 4.90 |
| Net profit (TTM) | $267.73M | $118.09B |
| Revenue (TTM) | $3.96B | $302.97B |
| Provider revenue period date | 2026-10-01 | 2026-07-25 |
| Revenue growth (YoY) | -5.0% | +105.9% |
| Gross margin | 40.8% | 74.7% |
| Operating margin | 8.6% | 65.2% |
| Net margin | 4.3% | 63.7% |
| Free cash flow (TTM) | $198.80M | $127.01B |
| Provider cash-flow period date | 2026-10-01 | 2026-07-25 |
| Ownership & sentiment | ||
| Institutional ownership | 79.1% | 70.2% |
| Insider activity (12mo) | 31 buy / 19 sell | 13 buy / 36 sell |
| Short interest (% of float) | 10.2% | 1.2% |
| Analyst consensus | 10% buy / 60% hold / 30% sell (10) | 67% buy / 30% hold / 2% sell (43) |
| Analyst price target | $86 (+16%) | $233 (+86%) |
| StockVane view | ||
| StockVane Quant Rating | C (65) | E (13) |
| Company | ||
| Employees | 10,000 | 42,000 |
| Founded | 1962 | 1993 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.